Primary Record
Levetiracetam
- In stock
- 3,867 g
- Purity
- 98.6 %
- CAS
- 102767-28-2
Compound Identifiers & Properties
- CAS
- 102767-28-2
- PubChem CID
- 5284583
- SMILES
- CC[C@@H](C(=O)N)N1CCCC1=O
- Canonical SMILES
- CC[C@@H](C(N)=O)N1CCCC1=O
Names & Synonyms
- Levetiracetam
- Keppra
- 102767-28-2
- Etiracetam
- Spritam
- Keppra XR
- matever
- Levetiracetamum
- Levetiracetame
- Elepsia
- Levroxa
- (S)-2-(2-Oxopyrrolidin-1-yl)butanamide
- Leviteracetam
- Levipil
- Torleva
- Levetiracetam sun
- E Keppra
- Elepsia XR
- Levetiracetam teva
- ucb L059
- Levetriacetam
- Levetiractam
- Desitrend
- Roweepra
- Levetiracetam [INN]
- Levetiracetam accord
- Levetiracetam actavis
- Levetiracetam hospira
- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-Levetiracetam
- Levetiracetam ER
- Etiracetam, R
- Etiracetam, S
- UCB-L 059
- Levetiracetam oral
- Keppra (TN)
- Levetiracetam CRS
- Etiracetam, S-
- Keppra;Keppra XR
- Levesam 500
- etiracetam, S-isomer
- UCB-L059
- Levetiracetam solution
- Etiracetam levo-isomer
- R-isomer Etiracetam
- S-isomer Etiracetam
- (-)-Levetiracetam
- E keppra (TN)
- LEVERTIRACETAM
- LEVITIRACETAM
- Levetiracetamum [INN-Latin]
- SIB-S1
- ucb L060
- Levetiracetam Injection
- RefChem:5943
- LEVETIRACETAM-D6
- AC1NR4PY
- C8H14N2O2
- ucb-L060
- UcbL060
- Levetiracetam Levetiracetam
- LEVETIRACETAM [MI]
- Levetiracetam In Sodium Chloride
- MFCD03265610
- UCB-22059
- D01XRM
- D0E1XL
- LEVETIRACETAM [JAN]
- LEVETIRACETAM RATIOPHARM
- AGB-101
- N03AX14
- (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- CHEBI:6437
- CHEMBL1286
- LEVETIRACETAM [HSDB]
- LEVETIRACETAM [USAN]
- UCB 22059
- DTXSID9023207
- LEVETIRACETAM [VANDF]
- Levetiracetam-d3 (contains d0)
- UNII-44YRR34555
- HSDB 7528
- Levetiracetam Extended-release
- MLS000759403
- MLS001424069
- MLS006010215
- BIDD:GT0242
- Levetiracetam (1359404)
- LEVETIRACETAM [MART.]
- Levetiracetam Working Standard
- NSC-760119
- SCHEMBL118843
- LEVETIRACETAM [USP-RS]
- LEVETIRACETAM [WHO-DD]
- LEVETIRACETAM ACTAVIS GROUP
- DTXCID503207
- ELEPSIA XR 1000 MG
- ELEPSIA XR 1500 MG
- GTPL6826
- Levetiracetam (JAN/USP/INN)
- orb1310850
- SCHEMBL6650425
- 44YRR34555
- LEVETIRACETAM [EMA EPAR]
- UCB-L059, SIB-S1
- (-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- CTK3J2270
- KS-00000ILW
- Levetiracetam, 98% - 1g 1g
- UCB-L-059
- Levetiracetam [USAN:USP:INN:BAN]
- UCB6474
- 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-
- HPHUVLMMVZITSG-LURJTMIESA-N
- Keppra, Keppra XR),Levetiracetam
- Levetiracetam - Bio-X trade mark
- Levetiracetam, >=98% (HPLC)
- Levetiracetam, analytical standard
- GLXC-03020
- HMS2051D07
- HMS2089L20
- HMS2235I18
- HMS3262H11
- HMS3713P16
- HMS3884O11
- Levetiracetam, 1mg/ml in Methanol
- Pharmakon1600-01502265
- LEVETIRACETAM [EP IMPURITY]
- LEVETIRACETAM [ORANGE BOOK]
- ACT02712
- ALBB-027275
- BCP11856
- HY-B0106
- Levetiracetam CRS (Y0001253)
- MSK10598
- UCB 6474
- UCB-6474
- ZINC1547851
- LEVETIRACETAM [EP MONOGRAPH]
- LEVETIRACETAM [USP IMPURITY]
- Tox21_500835
- (S)-2-(2-Oxopyrrolizino)butanamide
- (S)-2-(2-Oxopyrrolizino)butyramide
- ANW-41693
- BDBM50422542
- C8-H14-N2-O2
- EBC-06279
- LEVETIRACETAM [USP MONOGRAPH]
- NSC760119
- s1356
- STL388027
- Levetiracetam 1.0 mg/ml in Methanol
- (S)-2-(2-Oxo-1-pyrrolidinyl)butyramide
- AKOS015841981
- AC-1479
- CCG-100928
- CID5284583
- CS-1854
- DB01202
- FL24879
- KS-1176
- LP00835
- LS41261
- NC00178
- NSC 760119
- RP23251
- RTC-063977
- SDCCGSBI-0633760.P001
- (2S)-(2-Oxopyrrolidin-1-yl)butyramide
- alpha ethyl 2 oxo 1 Pyrrolidineacetamide
- L-059
- NCGC00186028-01
- NCGC00186028-13
- NCGC00261520-01
- (S)-2-(2-oxopyrrolidin-1-yl)butyramide
- AJ-26885
- BC208262
- BL164623
- BR-72955
- CJ-24357
- CPD000466303
- SAM001246539
- SC-15831
- SMR000466303
- (s)-2-(2-oxopyrrolidin-1-yl) butyramide
- 1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-
- (2S)-2-(2-oxo-1-pyrrolidinyl)butanamide
- AB0012613
- AB2000064
- J523.599E
- LS-137054
- ST2408279
- TL8000131
- (a-S)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
- A1198
- AM20070676
- FT-0602577
- FT-0630576
- FT-0670771
- L0234
- SW197558-3
- (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
- 2(S)-(2-OXOPYRROLIDIN-1-YL)BUTYRAMIDE
- C07841
- D00709
- EN300-244575
- M-2814
- AB00639945-06
- AB00639945_07
- AB00639945_08
- 1-Pyrrolidineacetamide, Alpha-ethyl-2-oxo-,(S)-
- 767L282
- A800616
- F079444
- SR-01000759400
- (2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide
- (alpha S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- (S)-2-(2-OXO-PYRROLIDIN-1-YL)-BUTYRAMIDE
- 1-Pyrrolidineacetamide, |A-ethyl-2-oxo-, (|AS)-
- SR-01000759400-4
- SR-01000759400-5
- BRD-K49404994-001-09-1
- BRD-K49404994-001-10-9
- BRD-K49404994-001-11-7
- Z1255435426
- (ALPHAS)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE
- (-)-(S)-.ALPHA.-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE
- 1-Pyrrolidineacetamide, .alpha.-ethyl-2-oxo-, (.alpha.S)-
- Levetiracetam Working Standard (Secondary Reference Standard)
- Levetiracetam, European Pharmacopoeia (EP) Reference Standard
- Levetiracetam, United States Pharmacopeia (USP) Reference Standard
- 33996-58-6
- (-)-(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide (2S)-2-(2-Oxo-pyrrolidin-1-yl)butanamide
- Levetiracetam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- Levitiracetam, Pharmaceutical Secondary Standard; Certified Reference Material
- 1-Pyrrolidineacetamide, a-ethyl-2-oxo-, (S)-; (aS)-a-Ethyl-2-oxo-1-pyrrolidineacetamide; (-)-(S)-a-Ethyl-2-oxo-1-pyrrolidineacetamide; (-)-Levetiracetam; (2S)-2-(2-Oxopyrrolidin-1-yl)butanamide; (S)-2-(2-Oxopyrrolidin-1-yl)butanamide; (S)-Levetiracetam; AGB 101; AGB 101 (low-dose levetiracetam); Keppra; Levesam; Levesam 500; Levipil; Levroxa; Matever; Spritam; UCB-L 059; Varuby
- 1-Pyrrolidineacetamide, a-ethyl-2-oxo-; a-Ethyl-2-oxo-1-pyrrolidineacetamide; Etiracetam; UCB 6474; (2RS)-2-(2-Oxopyrrolidin-1-yl)butanamide
- 1133229-30-7
- 114915-28-5
- 600-348-9
- UKX